Argent BioPharma Limited (ASX:RGT)
Australia · Delayed Price · Currency is AUD 0.0380
-0.0030 (-7.32%)
Aug 11, 2026, 3:56 PM AEST
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of 4.56 million as of August 11, 2026. Its market cap has decreased by -13.55% in one year.
Market Cap
4.56M
Enterprise Value
10.63M
Revenue
347.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has increased from 3.12M to 4.56M, an increase of 46.13%. That is a compound annual growth rate of 2.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 4.56M | -21.95% |
| Dec 31, 2025 | 5.84M | -36.74% |
| Dec 31, 2024 | 9.23M | -46.77% |
| Dec 29, 2023 | 17.33M | -45.96% |
| Dec 30, 2022 | 32.07M | -67.88% |
| Dec 31, 2021 | 99.85M | 123.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medical Developments International | 55.20M |
| Peak Processing | 21.26M |
| IDT Australia | 20.52M |
| Vitura Health | 16.57M |
| ECS Botanics Holdings | 9.58M |
| Epsilon Healthcare | 9.34M |
| Cann Group | 4.98M |
| BPH Global | 4.71M |